Ledger.Open graph →
SEC Form D · filed February 26, 2021

Artax Biopharma, Inc

Offering
$3.0M
Sold
$2.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Robert M. Armstrong, Ph.D · Cambridge, MADirectorJoseph M. Lobacki · Cambridge, MAExec · DirectorAlan E. Walts · Cambridge, MADirectorDamia M. Tormo · Cambridge, MADirectorGino M. Santini · Cambridge, MADirectorDrew Anwyll · Toronto, Ontario, CanadaDirectorKen Deregt · New York, NYDirectorBonnie Gurry · New York, NYDirectorEdwin Kania · LOS ANGELES, CADirectorMark Reynoso · LOS ANGELES, CAExec · DirectorArne Brock-Utne · Lafayette, CADirectorWarren A. Heffelfinger · Lafayette, CAExec · DirectorRami Elghandour · Gaithersburg, MDDirectorDavid T. Lubner · Gaithersburg, MDDirectorSabri Murat Bicer · Palo Alto, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗